Morin (C5297): Natural Flavonoid Antioxidant and Mitochondrial Modulator for Advanced Disease Models

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a natural flavonoid antioxidant with proven inhibition of adenosine 5′-monophosphate deaminase (AMPD), resulting in the modulation of mitochondrial energy metabolism under metabolic stress (Yang et al., 2025). It exhibits multi-faceted bioactivity, including anti-inflammatory, cardioprotective, neuroprotective, anti-diabetic, and antimicrobial effects, validated in both in vitro and in vivo disease models (APExBIO). Morin is uniquely suited as a fluorescent biochemical probe for aluminum ion detection due to its chelating properties. High-purity Morin (≥96.81%) is available from APExBIO, with detailed analytical validation (HPLC, MS, NMR). Its solubility and storage profile enable precise integration into advanced translational workflows. This article provides atomic, verifiable facts and benchmarks to guide researchers deploying Morin in disease modeling and mitochondrial studies.

Biological Rationale

Morin is a polyphenolic compound isolated from Maclura pomifera and other plant sources (APExBIO). It is chemically characterized as 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, with a molecular weight of 302.24 Da. Morin acts as a natural flavonoid antioxidant, scavenging reactive oxygen species (ROS) and chelating metal ions. These properties underpin its utility in protecting cells from oxidative and metabolic stress. Podocytes, neurons, and cardiomyocytes—cell types with high energy demands—are particularly susceptible to mitochondrial dysfunction. Morin’s modulation of mitochondrial energy metabolism is clinically relevant, especially in the context of metabolic syndrome, diabetes, and neurodegenerative conditions (Yang et al., 2025). The compound’s ability to inhibit AMPD activity interrupts the purine nucleotide cycle, thereby conserving ATP and supporting cellular viability under stress conditions. Its additional role as a fluorescent probe for aluminum ions expands its applications to biochemical detection workflows (Amyloid.co). This article extends the foundational insights from "Morin: Natural Flavonoid Antioxidant for Advanced Disease..." by providing direct benchmarks and atomic claims for translational model systems.

Mechanism of Action of Morin

Morin’s primary mechanism involves competitive inhibition of adenosine 5′-monophosphate deaminase (AMPD), specifically the AMPD2 isoform. This inhibition disrupts the purine nucleotide cycle, reducing the conversion of AMP to IMP, and consequently preserving intracellular ATP levels (Yang et al., 2025). Under high-fructose or metabolic stress conditions, AMPD activity is upregulated, leading to increased ATP depletion and mitochondrial dysfunction. Morin’s binding affinity for AMPD2 has been validated by molecular docking studies, with direct suppression of enzyme activity observed in both rat and mouse podocyte models. By preserving mitochondrial ultrastructure and function, Morin mitigates energy failure and prevents downstream injury in glomerular, neural, and cardiac tissues. Its anti-inflammatory, anti-apoptotic, and cytoprotective roles are mediated through modulation of mitochondrial pathways, ROS scavenging, and interference with pro-inflammatory signaling cascades. For aluminum ion detection, Morin’s hydroxyl groups enable selective formation of fluorescent complexes, allowing for sensitive and specific probe applications.

Evidence & Benchmarks

• Morin inhibits AMPD activity in vivo and in vitro, preventing ATP depletion and mitochondrial impairment in podocyte models exposed to 5 mM fructose (Yang et al., 2025).
• Morin administration (50 mg/kg/day, oral, 8 weeks) in high-fructose-diet-fed rats reduced urinary albumin-to-creatinine ratio (UACR) and restored synaptopodin expression—markers of glomerular protection (Yang et al., 2025).
• Mitochondrial ultrastructural integrity, measured by electron microscopy, was preserved in Morin-treated animals compared to controls (see Table 1, Yang et al., 2025).
• Morin solutions in DMSO are stable up to ≥19.53 mg/mL; in ethanol, ≥6.04 mg/mL; both are recommended for short-term use and storage at -20°C for maximal stability (APExBIO).
• High-purity Morin (≥96.81%) is confirmed by HPLC, MS, and NMR, supporting reproducibility in biochemical and cellular assays (APExBIO).
• Fluorescent chelation assays demonstrate Morin’s high selectivity for Al³⁺ ions over other divalents, enabling its use as a sensitive probe in bioanalytical workflows (Amyloid.co).
• Morin shows negligible solubility in water under neutral pH, requiring organic solvents for experimental use (APExBIO).
• AMPD2 knockdown experiments confirm the central role of this isoform in fructose-induced mitochondrial dysfunction, with Morin phenocopying the protective effects (Yang et al., 2025).

This article extends the mechanistic and benchmarking details found in "Morin (C5297): Mechanisms, Benchmarks, and Research Appli..." by incorporating new in vivo findings and validated workflow parameters.

Applications, Limits & Misconceptions

Core Applications

• Diabetes Research: Morin mitigates mitochondrial dysfunction and podocyte injury in high-fructose and diabetic models (Yang et al., 2025).
• Cancer Research: As a natural flavonoid, Morin exhibits cytotoxicity and metabolic modulation applicable to cancer cell viability assays (A77-01.com), clarifying use-cases compared to prior scenario-driven guidance.
• Neurodegenerative Disease Models: Morin’s antioxidant and mitochondrial stabilization properties are leveraged in neuronal cell assays (Traf2.com), with this article directly detailing evidence-based parameterization for such studies.
• Fluorescent Aluminum Ion Probe: Morin’s chelation-driven fluorescence is used in environmental and bioanalytical detection workflows (Amyloid.co).

Common Pitfalls or Misconceptions

• Morin is not water-soluble: Attempting to use Morin in aqueous buffers without organic co-solvents (DMSO, ethanol) leads to precipitation and assay failure (APExBIO).
• Not a panacea for all mitochondrial dysfunctions: Morin’s efficacy is context-dependent; it ameliorates energy imbalance primarily in AMPD-driven and high-fructose models (Yang et al., 2025).
• Specificity for AMPD2: While Morin inhibits AMPD2, other isoforms or off-target enzymes may not be affected equivalently (Yang et al., 2025).
• Short-term use of solutions: Morin solutions degrade over time; long-term stock storage at room temperature is not recommended (APExBIO).
• Not a therapeutic agent for clinical use: Morin supplied by APExBIO is for research use only and is not approved for human or veterinary therapeutic applications.

Workflow Integration & Parameters

Morin (C5297) is supplied at ≥96.81% purity, validated by HPLC, MS, and NMR. The compound is insoluble in water but dissolves readily in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL). For cellular assays, prepare fresh stock solutions and dilute in culture medium with ≤0.1% final solvent concentration to avoid cytotoxicity. Store dry powder and solutions at -20°C; avoid repeated freeze-thaw cycles. For fluorescent probe applications, calibrate excitation/emission settings to the Morin-Al³⁺ complex. In enzyme inhibition assays, titrate Morin concentrations against AMPD activity using established protocols. For mitochondrial studies, monitor endpoints such as ATP levels, oxygen consumption rate (OCR), and ultrastructural integrity by electron microscopy. Further scenario-driven guidance is provided in "Morin (C5297): Reliable Solutions for Cell Viability and ...", which this article updates with new purity and workflow best practices.

For procurement and technical specifications, refer to the Morin C5297 product page by APExBIO.

Conclusion & Outlook

Morin is a validated natural flavonoid antioxidant and mitochondrial modulator with robust evidence for its use in disease modeling, metabolic, and biochemical detection workflows. Its high specificity for AMPD2 and proven probe utility distinguish it in translational research. Continued benchmarking and scenario-driven optimization will further establish Morin as a reference standard for advanced cell viability and metabolism studies. For comprehensive mechanistic insights and translational guidance, see "Morin: Bridging Mechanistic Insights and Translational Br...", which this article extends by including new in vivo and workflow data. For ordering and documentation, visit APExBIO’s Morin (C5297) page.